Prestige Consumer Healthcare Inc. (FRA:PBV)

Market Cap	2.43B -35.6%
Revenue (ttm)	939.94M -1.3%
Net Income	158.84M -12.8%
EPS	3.23 -11.0%
Shares Out	n/a
PE Ratio	15.31
Forward PE	12.34
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	9
Open	51.50
Previous Close	52.00
Day's Range	51.50 - 51.50
52-Week Range	49.20 - 79.00
Beta	n/a
RSI	37.60
Earnings Date	May 8, 2026

About FRA:PBV

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mo...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 600
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PBV

Financial Performance

In fiscal year 2025, FRA:PBV's revenue was $1.14 billion, an increase of 1.10% compared to the previous year's $1.13 billion. Earnings were $214.61 million, an increase of 2.52%.

Financial numbers in USD